Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre

Fig. 1

Treatment (Tx) outcomes for each distinct LoT (up to 6 LoT shown), including status at end of study. The percentage of patients receiving subsequent treatment (shown by an arrow between bars) is labelled. The numbers of patients dying before receiving subsequent treatment are distinguished from those remaining alive without a change of treatment before end of study period

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us